04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
El 31 de julio de 2019, se publicó en el Diario Oficial de la Federación el Protocolo para la Legiti...
Read More >
After much consultation and heated debate, Vietnam adopted a new Labor Code on 20 November 2019 ("La...
Read More >
In our previous client alert, we reported that certain key changes were introduced to the United Ara...
Read More >
Seyfarth Synopsis: As the future of work continues to take shape, labor unions are taking notice and...
Read More >
Parties to a construction contract often consider entering into a letter of intent in advance of ag...
Read More >
The Internal Revenue Service has announced the 2020 limits that affect the operation of tax-qualifie...
Read More >